OBJECTIVES: The experiment aimed to explore the effects of curcumin on motor impairment, dopamine neurons, and gut microbiota in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mice model. METHODS: Mice were randomly assigned to six groups: normal control group, solvent control group, MPTP group, curcumin-low-dose group (40 mg/kg), curcumin-medium-dose group (80 mg/kg), and curcumin-high-dose group (160 mg/kg). After 14 days, each group of mice was subjected to the pole text, the hanging test, and the open-field test. Tyrosine hydroxylase (TH) immunohistochemistry was used to observe the survival of nigrostriatal dopamine neurons. Moreover, ultrastructural changes were observed with a transmission electron microscope in mice striatal tissue cells. Then, 16S rRNA was used to assess changes in the gut microbiota. RESULTS: (1) Each dose of curcumin reduced pole climbing time and increased suspension score and total distance moved dose-dependently. (2) All curcumin groups improved cell wrinkling and vacuolar degeneration, increased the number of TH positives, improved cell survival, and the higher the dose of curcumin, the better the effect. (3) There were differences in microbiota composition and a relative abundance among the groups. The relative abundance of Patescibacteria, Proteobacteria, and Verrucomicrobia was higher in the MPTP group. The relative abundance of Patescibacteria, Enterobacteriaceae, Enterococcaceae all decreased in all curcumin groups. In addition, the Kyoto Encyclopedia of Genes and Genomes pathways showed a reduction in the superpathway of N-acetylneuraminate degradation after medium- and high-dose curcumin administration. CONCLUSIONS: Curcumin regulates gut microbiota and exerts a neuroprotective effect in the MPTP mice model. This preliminary study demonstrates the therapeutic potential of curcumin for Parkinson's disease, providing clues for microbially targeted therapies for Parkinson's disease.
Experiment 1
Needs review
Curated date: 2024/03/12
Curator:
Revision editor(s):
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Mus musculus
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Curcumin (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione,C21,C21H20O6,COc1cc(ccc1O)\\\\C=C\\\\C(=O)CC(=O)\\\\C=C\\\\c1ccc(O)c(OC)c1,DC42,Diferuloylmethane,FLJ12894,InChI=1/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+,InChIKey=VFLDPWHFBUODDF-FCXRPNKRBF,IRA1,Kacha haldi,Natural yellow 3,TBL1XR1 wt Allele,TBLR1,Transducin (Beta)-Like 1 X-Linked Receptor 1 wt Allele,Transducin (Beta)-Like 1X-Linked Receptor 1 Gene,Turmeric yellow,Curcumin,curcumin
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- MPTP
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CUR-L
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Curcumin low-dose (CUR-L) group received a combination of both treatments in
which curcumin (40 mg/kg)
- Group 0 sample size Number of subjects in the control (unexposed) group
- 12
- Group 1 sample size Number of subjects in the case (exposed) group
- 12
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 3
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Reviewed Marked as Reviewed by Svetlana up on 2024-7-1
Source: Fig 5 and Text
Description: Differential distribution of Specie in the gut Microbiota between MPTP and CUR-L.
Abundance in Group 1: increased abundance
in
NCBI | Quality Control | Links |
---|
Adlercreutzia | | |
Adlercreutzia equolifaciens | | |
Alistipes | | |
Alistipes inops | | |
Alistipes sp. S457 | | |
Alloprevotella | | |
Alloprevotella tannerae | | |
Anaeroplasma | | |
Anaeroplasmataceae | | |
Anaeroplasmatales | | |
Anaerotignum | | |
Anaerotignum sp. | | |
Bacteroidales | | |
Bacteroidia | | |
Candidatus Gastranaerophilales | | |
Cyanobacteriota | | |
Cyanobacteriota/Melainabacteria group | | |
Eggerthellaceae | | |
Eggerthellales | | |
Lachnoclostridium | | |
Lachnoclostridium sp. | | |
Lactobacillus sp. L-YJ | | |
Paramuribaculum | | |
Paramuribaculum intestinale | | |
Prevotellaceae | | |
Rikenellaceae | | |
[Eubacterium] brachy | | |
unclassified Anaeroplasma | | |
unclassified Candidatus Gastranaerophilales | | |
unclassified sequences | | |
uncultured Clostridium sp. | | |
Eubacterium brachy group unclassifedEubacterium brachy group unclassifed | | |
Revision editor(s): MyleeeA,
WikiWorks
Signature 2
Reviewed Marked as Reviewed by Svetlana up on 2024-7-1
Source: Fig 5 and Text
Description: Differential distribution of Specie in the gut Microbiota between MPTP and CUR-L
.
Abundance in Group 1: decreased abundance
in
NCBI | Quality Control | Links |
---|
Akkermansia | | |
Akkermansia muciniphila | | |
Akkermansiaceae | | |
Atopobiaceae | | |
Bacteria | | |
Candidatus Saccharimonadaceae | | |
Candidatus Saccharimonadales | | |
Candidatus Saccharimonadia | | |
Candidatus Saccharimonas | | |
Eubacteriaceae | | |
Eubacterium | | |
Intestinimonas | | |
Lentilactobacillus hilgardii | | |
Limosilactobacillus reuteri | | |
Muribaculum intestinale | | |
Patescibacteria group | | |
Verrucomicrobiales | | |
Verrucomicrobiia | | |
Verrucomicrobiota | | |
unclassified Candidatus Saccharimonas | | |
unclassified Intestinimonas | | |
uncultured Bifidobacterium sp. | | |
Coriobacteriaceae_UCG_002Coriobacteriaceae_UCG_002 | | |
Coriobacteriaceae_UCG_002_unclassifedCoriobacteriaceae_UCG_002_unclassifed | | |
Revision editor(s): MyleeeA,
WikiWorks
Experiment 2
Needs review
Curated date: 2024/03/14
Curator:
Revision editor(s):
Differences from previous experiment shown
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CUR-M
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Curcumin Medium-dose (CUR-M) group received a combination of both treatments in which curcumin (80 mg/kg)
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Reviewed Marked as Reviewed by Svetlana up on 2024-7-1
Source: Fig 5 and Text
Description: Differential distribution of Specie in the gut Microbiota between MPTP and CUR-M.
Abundance in Group 1: increased abundance
in
NCBI | Quality Control | Links |
---|
Bacteroides acidifaciens | | |
Betaproteobacteria | | |
Burkholderiaceae | | |
Eggerthellaceae | | |
Enterorhabdus | | |
Eubacterium coprostanoligenes | | |
Lachnoclostridium sp. | | |
Paramuribaculum | | |
Paramuribaculum intestinale | | |
Prevotellaceae | | |
Pseudomonadaceae | | |
Pseudomonadales | | |
Pseudomonas | | |
Pseudomonas sp. DENB20 | | |
Rikenellaceae | | |
unclassified Enterorhabdus | | |
uncultured Streptococcus sp. | | |
Ruminococcaceae UCG 010 unclassifedRuminococcaceae UCG 010 unclassifed | | |
Eubacterium coprostanoligenes group unclassifedEubacterium coprostanoligenes group unclassifed | | |
Ruminococcaceae UCG 010Ruminococcaceae UCG 010 | | |
Revision editor(s): MyleeeA,
WikiWorks
Signature 2
Reviewed Marked as Reviewed by Svetlana up on 2024-7-1
Source: Fig 5 and Text
Description: Differential distribution of Specie in the gut Microbiota between MPTP and CUR-M.
Abundance in Group 1: decreased abundance
in
NCBI | Quality Control | Links |
---|
Acetatifactor | | |
Acetatifactor sp. | | |
Eubacteriaceae | | |
Eubacterium | | |
Lentilactobacillus hilgardii | | |
Limosilactobacillus reuteri | | |
uncultured Eubacterium sp. | | |
Coriobacteriaceae UCG 002 unclassifedCoriobacteriaceae UCG 002 unclassifed | | |
Coriobacteriaceae UCG 002Coriobacteriaceae UCG 002 | | |
Revision editor(s): MyleeeA,
WikiWorks
Experiment 3
Needs review
Curated date: 2024/03/14
Curator:
Revision editor(s):
Differences from previous experiment shown
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CUR-H
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Curcumin High-dose (CUR-H) group received a combination of both treatments in which curcumin (160 mg/kg)
Lab analysis
Statistical Analysis
Alpha Diversity
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Reviewed Marked as Reviewed by Svetlana up on 2024-7-1
Source: Fig 5 and Text
Description: Differential distribution of Specie in the gut Microbiota between MPTP and CUR-H.
Abundance in Group 1: increased abundance
in
NCBI | Quality Control | Links |
---|
Actinomycetota | | |
Allobaculum | | |
Bacillota | | |
Coriobacteriales | | |
Coriobacteriia | | |
Eggerthellaceae | | |
Enterorhabdus | | |
Intestinimonas | | |
Lactobacillus sp. L-YJ | | |
Mollicutes | | |
Mycoplasmatota | | |
Paramuribaculum | | |
Paramuribaculum intestinale | | |
Pseudomonadaceae | | |
Pseudomonadales | | |
Pseudomonas | | |
Pseudomonas sp. DENB20 | | |
unclassified Enterorhabdus | | |
unclassified Intestinimonas | | |
uncultured Allobaculum sp. | | |
uncultured Ruminiclostridium sp. | | |
Ruminiclostridium 9Ruminiclostridium 9 | | |
Revision editor(s): MyleeeA,
WikiWorks
Signature 2
Reviewed Marked as Reviewed by Svetlana up on 2024-7-1
Source: Fig 5 and Text
Description: Differential distribution of Specie in the gut Microbiota between MPTP and CUR-H.
Abundance in Group 1: decreased abundance
in
NCBI | Quality Control | Links |
---|
Candidatus Saccharimonadales | | |
Candidatus Saccharimonadia | | |
Eubacteriaceae | | |
Eubacterium | | |
Eubacterium coprostanoligenes | | |
Holdemania | | |
Holdemania massiliensis | | |
Lentilactobacillus hilgardii | | |
Limosilactobacillus reuteri | | |
Patescibacteria group | | |
[Eubacterium] nodatum | | |
unclassified Candidatus Saccharimonas | | |
uncultured Bacteroides sp. | | |
uncultured Eubacterium sp. | | |
Eubacterium nodatum group unclassifedEubacterium nodatum group unclassifed | | |
Eubacterium coprostanoligenes groupEubacterium coprostanoligenes group | | |
Family XIIIFamily XIII | | |
Candidatus Saccharimonas | | |
Revision editor(s): MyleeeA,
WikiWorks